Journal: Purinergic Signalling
Article Title: Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients
doi: 10.1007/s11302-018-9642-3
Figure Lengend Snippet: The expression of CD39 and CD73 on MVs was evaluated by flow cytometry. Representative flow cytometry dot-plots showed the MVs labeled to CD39 (a) and CD73 (c). The percentage of labeling was demonstrated at (b) and (d), respectively. Annexin-V was used to identify phosphatidylserine that is present at the MV membrane [20]. Data were expressed as mean ± SEM (n = 6) and analyzed by two-way ANOVA, followed by Bonferroni’s post-hoc test
Article Snippet: Chemicals Adenosine-5′triphosphate (ATP), adenosine-5′diphosphate (ADP), adenosine-5′monophosphate (AMP), α-β-methylene-ADP (APCP; inhibitor of CD73), {"type":"entrez-protein","attrs":{"text":"ARL67156","term_id":"1186396857","term_text":"ARL67156"}} ARL67156 (inhibitor of NTPDases), levamisole (inhibitor of alkaline phosphatase), Malachite Green, Coomassie Blue, and Tris–HCl were purchased from Sigma Aldrich.
Techniques: Expressing, Flow Cytometry, Labeling